Insider · CIK 0001106519

GILL DAVID N

Reports to the SEC for 13 companies · NORTH MELBOURNE

sec.gov

Transactions

Companies

Filings

CIK

0001106519

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-17	EOLSEvolus, Inc.A Award	Director	AAward	+45.6K sh	—	—	86,887
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.5K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−25.1K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−33.5K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−5,825 sh	$8.60	−$50.1K	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−11K sh	—	—	0
2025-09-16	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−24K sh	—	—	0
2025-06-30	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+33.5K sh	—	—	33,450
2025-06-30	Y-mAbs Therapeutics, Inc.A Award	Director	AAward	+25.1K sh	—	—	30,905
2025-03-07	EOLSEvolus, Inc.A Award	Director	AAward	+7,364 sh	—	—	41,328
2025-03-07	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.1K sh	—	—	11,146
2024-06-11	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+14.5K sh	—	—	14,545
2024-06-11	Y-mAbs Therapeutics, Inc.A Award	Director	AAward	+3,495 sh	—	—	5,825
2024-05-14	EOLSEvolus, Inc.S Sale	Director	SSale	−6,718 sh	$12.60	−$84.7K	33,964
2024-05-13	EOLSEvolus, Inc.S Sale	Director	SSale	−3,643 sh	$12.72	−$46.4K	40,682
2024-02-07	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,377 sh	—	—	9,377
2024-02-07	EOLSEvolus, Inc.A Award	Director	AAward	+6,464 sh	—	—	44,325
2023-06-08	Y-mAbs Therapeutics, Inc.Employee Stock Option (right to buy)A Award	Director	AAward	+14K sh	—	—	13,950
2023-06-08	Y-mAbs Therapeutics, Inc.A Award	Director	AAward	+2,330 sh	—	—	2,330
2023-01-27	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+11.8K sh	—	—	11,789
2023-01-27	EOLSEvolus, Inc.A Award	Director	AAward	+8,293 sh	—	—	37,861
2022-07-15	Y-mAbs Therapeutics, Inc.Non-Employee Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2022-05-16	EOLSEvolus, Inc.S Sale	Director	SSale	−5,000 sh	$13.62	−$68.1K	29,568
2022-05-13	EOLSEvolus, Inc.S Sale	Director	SSale	−5,313 sh	$13.10	−$69.6K	34,568
2022-01-24	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+22.7K sh	—	—	22,727
2022-01-24	EOLSEvolus, Inc.A Award	Director	AAward	+15.6K sh	—	—	39,881
2021-10-05	Strongbridge Biopharma plcD Disposition to Issuer	Director	DDisposition to Issuer	−78.1K sh	—	—	0
2021-10-01	Strongbridge Biopharma plcF Tax Payment	Director	FTax Payment	−17.8K sh	$2.06	−$36.6K	78,058
2021-06-10	Y-mAbs Therapeutics, Inc.Non-Employee Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2021-05-18	Strongbridge Biopharma plcA Award	Director	AAward	+40K sh	—	—	95,821
2021-05-14	Strongbridge Biopharma plcF Tax Payment	Director	FTax Payment	−19.1K sh	$2.35	−$44.8K	55,821
2021-02-05	EOLSEvolus, Inc.A Award	Director	AAward	+19.3K sh	—	—	24,313
2021-01-19	Y-mAbs Therapeutics, Inc.Non-Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	24,000
2021-01-19	Y-mAbs Therapeutics, Inc.S Sale	Director	SSale	−2,000 sh	$46.52	−$93K	0
2021-01-19	Y-mAbs Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$11.16	+$22.3K	2,000
2020-11-18	Y-mAbs Therapeutics, Inc.Non-Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,000 sh	—	—	26,000
2020-11-18	Y-mAbs Therapeutics, Inc.S Sale	Director	SSale	−2,000 sh	$45.77	−$91.5K	0
2020-11-18	Y-mAbs Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,000 sh	$11.16	+$22.3K	2,000
2020-11-03	Y-mAbs Therapeutics, Inc.M Exercise/Conversion	Director	MExercise/Conversion	+4,000 sh	$11.16	+$44.6K	4,000
2020-11-03	Y-mAbs Therapeutics, Inc.Non-Employee Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−4,000 sh	—	—	28,000
2020-11-03	Y-mAbs Therapeutics, Inc.S Sale	Director	SSale	−4,000 sh	$45.00	−$180K	0
2020-09-24	Strongbridge Biopharma plcP Purchase	Director	PPurchase	+8,000 sh	$2.13	+$17K	74,896
2020-09-03	Strongbridge Biopharma plcF Tax Payment	Director	FTax Payment	−23.1K sh	$3.61	−$83.4K	66,896
2020-06-23	Y-mAbs Therapeutics, Inc.Non-Employee Stock Option (right to buy)A Award	Director	AAward	+16K sh	—	—	16,000
2020-05-14	Strongbridge Biopharma plcA Award	Director	AAward	+40K sh	—	—	90,000
2020-01-23	EOLSEvolus, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.5K sh	—	—	23,458

Recent filings

Accepted (ET)
Feb 194
GILL DAVID N0001570562-26-000020
SEC(opens sec.gov)
Sep 184
GILL DAVID N0001106519-25-000005
SEC(opens sec.gov)
Jul 24
GILL DAVID N0001415889-25-019046
SEC(opens sec.gov)
Mar 114
GILL DAVID N0001570562-25-000039
SEC(opens sec.gov)
Jun 134
GILL DAVID N0001104659-24-071399
SEC(opens sec.gov)
May 154
GILL DAVID N0001570562-24-000090
SEC(opens sec.gov)
Feb 94
GILL DAVID N0001570562-24-000024
SEC(opens sec.gov)

Companies

Address

C/O TELIX PHARMACEUTICALS LTD 55 FLEMINGTON RD

NORTH MELBOURNE, 3051